中手游(00302.HK)「仙劍世界」雙端版號獲批
中手游(00302.HK)公布,國家新聞出版署官網公布新一批遊戲版號審批信息,公司自主研發重點打造的國內首款國風仙俠開放世界遊戲《仙劍世界》獲得移動端、客戶端版號。
公司指出,今年版號發放以來,中手游至今新獲版號的產品已有五款,其中包括中手游旗下全資子公司文脈互動研發,三七互娛國內獨代發行的《城主天下》、中手游旗下全資子公司軟星科技研發的強手棋類休閒遊戲《大富翁11》、在今年4月獲得版號的《異獸在山海》、中手游首款自研自發的3v3戰術競技籃球端游《全民街籃》,以及近日獲發移動端、客戶端版號的《仙劍世界》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.